Table 2 Resting echocardiography parameters in each group
From: Biomarkers and Echocardiographic Predictors of Myocardial Dysfunction in Patients with Hypertension
Mean ± standard deviation (SD) | p | |||||
---|---|---|---|---|---|---|
Parameter | Control Group (n = 22) | Dyspnea Group (n = 27) | HF Group (n = 50) | Control vs Dyspnea | Control vs Heart Failure | Dyspnea vs Heart Failure |
LVEDD (mm) | 50.8 ± 6 | 49.0 ± 5 | 63.2 ± 9.5 | ns | <0.0001 | <0.0001 |
LVESD (mm) | 30.5 ± 5 | 32.5 ± 6 | 48.1 ± 10 | ns | <0.0001 | <0.0001 |
LVEF (%) | 62.5 ± 4 | 59.5 ± 3 | 36.7 ± 10 | ns | <0.0001 | <0.0001 |
LA (mm) | 35.9 ± 5 | 37.1 ± 4 | 45.1 ± 7.7 | ns | <0.0001 | <0.0001 |
Dilated LA (%) | 36 | 26 | 74 | ns | <0.001 | <0.001 |
peak E cm/s | 70.1 ± 11 | 71.3 ± 18 | 62.9 ± 23 | ns | ns | ns |
peak A cm/s | 65.3 ± 23 | 70.3 ± 16 | 87.4 ± 13 | ns | 0.019 | ns |
E/A ratio | 1.1 ± 0.4 | 1.0 ± 0.3 | 0.6 ± 0.2 | ns | 0.012 | ns |
DT (ms) | 246.2 ± 58 | 267.7 ± 72 | 343.1 ± 106 | ns | ns | Ns |
LV mass (g) | 193.0 ± 51 | 194 ± 61 | 460 ± 244 | ns | 0.001 | 0.001 |
LVMI | 104.2 ± 31 | 103.7 ± 24 | 240 ± 132 | ns | 0.001 | 0.001 |
IVSD (mm) | 9.5 ± 1 | 9.3 ± 1 | 11.7 ± 2.3 | ns | 0.003 | <0.0001 |
PWD (mm) | 9.1 ± 1 | 9.3 ± 1 | 11.3 ± 2.8 | ns | 0.019 | 0.019 |
RVdD (mm) | 27.9 ± 3 | 26.8 ± 3 | 28.8 ± 4.8 | ns | ns | ns |
LVEDV (ml) | 85.8 ± 25 | 80.6 ± 21 | 213.5 ± 60 | ns | <0.0001 | <0.0001 |
LVESV (ml) | 29.8 ± 7 | 28.2 ± 8 | 135.5 ± 50 | ns | <0.0001 | <0.0001 |
TAPSE (mm) | 25.9 ± 3 | 24.5 ± 3 | 21.6 ± 3.6 | ns | 0.004 | ns |
IVRT (ms) Rest | 89.4 ± 26 | 104.8 ± 19 | 105.1 ± 15 | 0.03 | 0.03 | ns |
E' Rest (cm/s) | 10.5 ± 2 | 10.7 ± 2 | 6.4 ± 3 | ns | 0.01 | 0.01 |
A' Rest (cm/s) | 10.8 ± 3 | 11.3 ± 3 | 11.8 ± 2 | ns | ns | ns |
E/E' ratio Rest | 7.0 ± 2 | 7.0 ± 1 | 10.6 ± 5 | ns | 0.02 | 0.02 |
S' rest (cm/s) | 9.0 ± 2 | 9.0 ± 2 | 6.0 ± 3 | ns | 0.02 | 0.02 |